Blood lead concentrations among pediatric patients with abdominal pain: a prospective cross-sectional study

Amirhossein Hosseini1, Anahita Fayaz2, Hossein Hassanian-Moghaddam3,4

  • 1Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

BMC Gastroenterology
|December 21, 2021
PubMed

Insights

Nearly 20% of children with abdominal pain had elevated blood lead levels (BLLs). This highlights the importance of screening for lead poisoning in children presenting with abdominal pain due to its severe developmental impacts.

Area of Science:

  • Environmental Health
  • Pediatric Medicine
  • Toxicology

Background:

  • Lead exposure poses significant risks to children's health, affecting multiple organ systems and development.
  • Lead poisoning can manifest with symptoms such as colicky abdominal pain.
  • Previous adult lead poisoning epidemics raised concerns for pediatric cases.

Purpose of the Study:

  • To determine the prevalence of elevated blood lead levels (BLLs) in pediatric patients with abdominal pain.
  • To identify factors contributing to high BLLs in this population.

Main Methods:

  • A prospective cross-sectional study was conducted with 187 pediatric patients presenting with abdominal pain.
  • Data on demographics, environmental, and social factors were collected via questionnaires.
  • Blood samples were analyzed for BLLs and complete blood counts.

Main Results:

  • Approximately 20% of enrolled children had BLLs ≥ 5 µg/dL.
  • Significant predictors of high BLLs included younger age, lower weight and height, and playing with certain toys.
  • Maternal education level also correlated with children's blood lead concentrations.

Conclusions:

  • A substantial proportion of children with abdominal pain exhibit elevated BLLs.
  • Pediatric patients presenting with abdominal pain warrant careful evaluation for lead poisoning.
  • Early identification and intervention are crucial due to lead's adverse effects on neurodevelopment.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
15
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
325
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
15
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
229
Blood Studies I: ABG and VBG01:26

Blood Studies I: ABG and VBG

Blood studies are critical in the medical field, enabling healthcare professionals to assess a patient's health status accurately. This page will focus on two significant blood studies: Arterial Blood Gas (ABG) and Venous Blood Gas (VBG).
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to...
809
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
14